CLSI EP14-A3

Evaluation of Commutability of Processed Samples; Approved Guideline, Third Edition, EP14A3E

Clinical and Laboratory Standards Institute, 08/15/2014

Publisher: CLSI

File Format: PDF

$90.00$180.00


Published:15/08/2014

Pages:58

File Size:1 file , 2.6 MB

Note:This product is unavailable in Russia, Belarus

This guideline provides protocols that can evaluate commutability in any nonpatient processed samples when tested using quantitative measurement procedures. Such processed samples may be used for proficiency testing/external quality assessment (PT/EQA), measuring interval verification sample sets, or QC samples.

The guideline is intended to be used by developers of commercial diagnostic tests as well as laboratory-developed tests, manufacturers of measuring interval sample sets and QC samples, and PT or EQA providers. This guideline may also be useful to all clinical laboratory professionals wishing to investigate a processed sample's commutability.

More CLSI standard pdf

CLSI I/LA21-A2

CLSI I/LA21-A2

Clinical Evaluation of Immunoassays; Approved Guideline--Second Edition, ILA21A2E

$90.00 $180.00

CLSI C54-A-IR

CLSI C54-A-IR

Verification of Comparability of Patient Results Within One Health Care System; Approved Guideline

$105.00 $210.92

CLSI POCT02-A

CLSI POCT02-A

Implementation Guide of POCT01 for Health Care Providers; Approved Guideline, POCT02AE

$142.00 $285.24

CLSI M48-A

CLSI M48-A

Laboratory Detection and Identification of Mycobacteria; Approved Guideline, M48AE

$90.00 $180.00